A free meningitis B vaccine is being made available to approximately one million young people in England, following a significant outbreak in Kent earlier this year. The vaccine, which requires two doses, is aimed at 17 and 18-year-olds and those under 25 starting university or residential colleges for the first time this autumn.
Nearly 90,000 doses have already been administered, with additional appointments available at pharmacies. This initiative seeks to mitigate the risks associated with meningitis B, particularly among students who may be at higher risk due to close living conditions and social interactions.
With the rollout of the MenB vaccine, young people should prioritize getting both doses to ensure full protection, especially as they transition to university life. Watch for updates on vaccination rates and any potential expansions of the program to include older teens.